Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report

BMC Nephrology
Ryo KodaIchiei Narita

Abstract

Acute tubulointerstitial nephritis (ATIN) has been increasingly recognized as an important manifestation of kidney injury associated with the use of immune checkpoint inhibitors (anti-PD-1 and anti-CTLA-4). While the exact pathophysiology remains unknown, corticosteroids are the mainstay of management. We describe a 67-year-old man with stage IV non-small-cell lung cancer who developed kidney injury during treatment with the anti-PD-1 antibody nivolumab. A kidney biopsy showed ATIN without granuloma formation. Considering their mechanism of action, immune checkpoint inhibitors can alter immunological tolerance to concomitant drugs that have been safely used for a long time. For more than 4 years before the initiation of nivolumab therapy, the patient had been receiving the proton pump inhibitor lansoprazole, known to cause drug-induced ATIN, without significant adverse events including kidney injury. He showed rapid improvement in kidney function in 3 days (creatinine decreased from 2.74 to 1.82 mg/dl) on discontinuation of lansoprazole. He then received 500 mg intravenous methylprednisolone for 3 days followed by 1 mg/kg/day oral prednisolone and his creatinine levels eventually stabilized around 1.7 mg/dl. Drug-induced lympho...Continue Reading

References

Sep 9, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Roland SchoopRudolf P Wüthrich
Sep 1, 2006·Journal of the American Society of Nephrology : JASN·Zoi SpanouWerner J Pichler
Jan 11, 2008·Kidney International·E GonzálezUNKNOWN Grupo Madrileño De Nefritis Intersticiales
Jul 10, 2009·The New England Journal of Medicine·Fouad FadelBertrand Knebelmann
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerSuzanne L Topalian
Jul 20, 2010·Immunological Reviews·Loise M FranciscoArlene H Sharpe
Jan 10, 2012·Nature Medicine·Vijay K KuchrooCarola G Vinuesa
Jun 15, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Angela K MuriithiSamih H Nasr
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
Jan 12, 2016·JAMA Internal Medicine·Benjamin LazarusMorgan E Grams
Apr 27, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Anushree C ShiraliScott Gettinger
Jun 11, 2016·Kidney International·Frank B CortazarDavid E Leaf
Jul 2, 2016·JAMA Oncology·Claire F FriedmanMichael A Postow
Jan 12, 2017·American Journal of Nephrology·Rimda WanchooUNKNOWN Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors
Feb 13, 2017·Current Problems in Cancer·Naoka MurakamiLeonardo V Riella
Mar 13, 2017·Advances in Chronic Kidney Disease·Rajeev Raghavan, Saed Shawar
Mar 25, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hassan Izzedine, Mark A Perazella

❮ Previous
Next ❯

Citations

Jul 1, 2018·Journal of the American Society of Nephrology : JASN·Mark A Perazella, Anushree C Shirali
May 1, 2019·Expert Review of Clinical Pharmacology·Krishna Sury, Mark A Perazella
Feb 19, 2019·Case Reports in Nephrology·Panagiotis I GeorgianosPantelis E Zebekakis
Jul 8, 2020·International Journal of Molecular Sciences·Laura Martinez ValenzuelaJuan Torras
Jan 4, 2020·Journal of the American Society of Nephrology : JASN·Frank B CortazarDavid E Leaf
Oct 20, 2020·Frontiers in Oncology·Chaoyue SuJianye Zhang
Nov 10, 2020·Frontiers in Immunology·Rossana FranzinElena Ranieri
Feb 20, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M EspiD Fouque
Mar 4, 2021·International Journal of Molecular Sciences·Laura Martínez-ValenzuelaJoan Torras
Mar 8, 2021·BMC Nephrology·Colleen S Curran, Jeffrey B Kopp
Mar 27, 2021·Cancer Chemotherapy and Pharmacology·Łukasz MielczarekAnna M Czarnecka
Aug 11, 2020·KI Reports·Sandra M Herrmann, Mark A Perazella
Sep 3, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marc Pujalte-MartinDelphine Borchiellini
May 1, 2021·Frontiers in Immunology·Sean HammondDean Naisbitt
Jul 3, 2021·International Journal of Molecular Sciences·Ewa KwiatkowskaSebastian Kwiatkowski
Jun 25, 2021·Curēus·Kevin ParzaMaryam Gondal
Jul 15, 2021·Journal of Medical Case Reports·Takeshi OkamotoTeruo Yamauchi
Jul 11, 2021·Clinical Journal of the American Society of Nephrology : CJASN·Benjamin A AdamMichael Mengel
Feb 29, 2020·Case Reports in Oncology·Sachi OkawaTakuo Shibayama
Dec 2, 2021·Toxicological Sciences : an Official Journal of the Society of Toxicology·Sean HammondDean John Naisbitt

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Anushree C ShiraliScott Gettinger
The Journal of Clinical Endocrinology and Metabolism
Chen ZhaoIsaac Brownell
© 2022 Meta ULC. All rights reserved